Karel Erion

Karel Erion

Company: Capacity Bio

Job title: Director of Preclinical Research


Identification of a New Target to Enhance Mitophagy Flux & Treat Muscular Dystrophy 11:15 am

Unveiling of a novel target that potently enhances mitophagy flux in cells and in vivo when activated Overview of molecular data supporting mechanism of action which lead small molecule induces mitophagy In vivo data supporting beneficial effect of mitophagy induction in preclinical modelRead more

day: Day One

Developing & Validating Preclinical Disease Models for Chronic Diseases 12:00 pm

After many strategies for treating neurodegenerative and cardiometabolic diseases have seen little success, the role of mitochondrial dysfunction is moving to the forefront. Workshop highlights include: Understand the most recent research into mitochondrial dysfunction in aging Explore the latest cell engineering techniques Discover how to improve the translational efficacy of early disease models and improve…Read more

day: Pre-Conference Day

A Hanson Wade Group Company

© Copyright 2024 Hanson Wade | Design and site by Event Engine | Hanson Wade Limited is registered in England & Wales, number 06752216.
Registered Office: Eastcastle House, 27/28 Eastcastle Street, London, W1W 8DH.